Bordetella Pertussis Testing
Prevent the Preventable. Manage the Manageable.
Bordetella Pertussis (B. pertussis) infection incidence is on the rise, returning to pre-pandemic patterns with more than 10,000 cases per year.1
Bordetella Pertussis (B. pertussis) infection incidence is on the rise, returning to pre-pandemic patterns with more than 10,000 cases per year.1
Pertussis Testing and Diagnosis: Ensuring Early Detection
Bordetella Pertussis (B. pertussis) causes whooping cough, a respiratory infectious disease that can cause severe illness in children younger than 5 years. Pertussis is characterized by frequent cough attacks that can leave the patients out of breath. Pneumonia complications among young infants is the cause of most pertussis-associated deaths.2
Of the pertussis-associated deaths, 84% are children younger than 2 months of age.3
Pertussis is highly contagious, so early diagnosis is important in order to prevent the spread of disease.3
Pertussis remains a major health problem worldwide, with an estimated 24M cases globally among children younger than 5 years.3
Alethia Pertussis Testing Solutions for B. Pertussis (Whooping cough)
Molecular Testing is Recommended, as B. Pertussis is Difficult to Culture and Lacks Sensitivity
Meridian Bioscience diagnostic solution for the detection of B. Pertussis, which provides an accurate and reliable molecular assay from an NP swab in less than 1 hour.
Educational Resources About B. Pertussis Testing
As dedicated partners in enhancing patient care, we take pride in our diverse diagnostic portfolio and go further by offering educational content and tools, leveraging our expertise to boost testing utilization and support our partners comprehensively.
Frequently Asked Questions About B. Pertussis Testing
Whooping cough is an acute infectious disease cause by Bordetella Pertussis.2
The infection is characterized by a cough that gradually becomes more severe, with burst of numerous, rapid coughs usually accompanied by a characteristic high-pitched whoop.2
Molecular testing is recommended for the diagnosis of B. pertussis. These tests are sensitive and provide prompt, accurate results that can help with early treatment. A nasopharyngeal swab should be taken 0 to 3 weeks following cough onset.4